Patient Leaflet Updated 21-Aug-2024 | AbbVie Ltd
Produodopa 240 mg/ml + 12 mg/ml solution for infusion
Produodopa 240 mg/ml + 12 mg/ml solution for infusion
foslevodopa and foscarbidopa
1. What Produodopa is and what it is used for
2. What you need to know before you use Produodopa
3. How to use Produodopa
4. Possible side effects
5. How to store Produodopa
6. Contents of the pack and other information
7. Instructions for use for Produodopa infusion using the Vyafuser pump
Produodopa contains two active ingredients, foslevodopa and foscarbidopa, and is used to treat Parkinson’s disease.
Do not use Produodopa if any of the above apply to you. If you are not sure, talk to your doctor before using the medicine.
Talk to your doctor, pharmacist, or nurse before and during the use of Produodopa if you
If any of the above apply to you or if you are not sure, talk to your doctor before starting Produodopa.
Tell your doctor if you notice involuntary and uncontrollable movements of your limbs, back, neck, or chin (dyskinesias) or an increase in stiffness or slowness of movements. Your daily dose may need adjustments, or the device might be obstructed.
Neuroleptic Malignant Syndrome
Do not stop using Produodopa unless your doctor tells you to. This is because suddenly stopping or lowering your Produodopa dose quickly may cause a serious problem called ‘Neuroleptic Malignant Syndrome’. The signs may include
Impulse control disorders – changes in your behaviour
Tell your doctor if you, your family, or carer notices you are developing urges or cravings to behave in ways that are unusual for you, or you cannot resist the impulse, drive, or temptation to carry out certain activities that could harm yourself or others. These behaviours are called ‘impulse control disorders’ and can include
Your doctor may need to review your treatments. They will discuss ways of managing or reducing these symptoms with you (see also section 4 ‘Impulse control disorders – changes in your behaviour’).
Dopamine Dysregulation Syndrome
Tell your doctor if you, your family, or carer notices you are developing addiction-like symptoms leading to craving for large doses of Produodopa and other medicines used to treat Parkinson’s disease.
Infusion site infections
Tell your doctor if you notice any skin changes at the infusion site, such as redness, warmth, swelling, pain, or discolouration when you apply pressure to it. You should always follow aseptic (sterile) techniques while using this medicine and regularly change the infusion site (at least every third day), using a new infusion set. Make sure the new infusion site is at least 2.5 cm from a site used in the last 12 days. You may need to change the infusion site more often than every 3rd day, if you notice any of the above-mentioned skin changes.
Produodopa and cancer
In the body, foscarbidopa (a component of Produodopa) is broken down into something called ‘hydrazine’. It is possible that hydrazine could damage your genetic material which could lead to cancer. However, it is not known if the amount of hydrazine produced when taking a normal dose of Produodopa can cause this.
Produodopa is not recommended for children and adolescents under 18 years of age. This is because the medicine has not been studied in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, and herbal medicines.
Talk to your doctor or pharmacist before starting Produodopa if you are taking other medicines for
Tell your doctor or pharmacist if you are taking a COMT (catechol-O-methyl transferase) inhibitor as it may increase the levodopa amount in your blood. Your doctor may need to adjust the dose of either medicine.
Tell your doctor or pharmacist if you are taking medicines called sympathomimetic drugs such as - but not limited to - salbutamol, phenylephrine, isoproterenol, dobutamine to treat low blood pressure. Sympathomimetic medicines and levodopa can increase the risk of high blood pressure (hypertension) or irregular heartbeats (arrhythmia).
Tell your doctor or pharmacist if you are taking medicines known to be eliminated by an enzyme called ‘CYP1A2’. Examples of such medicines include:
Certain medicines (such as selegiline) that you take may lower your blood pressure, which may make you feel dizzy when you get up from a chair or bed (orthostatic hypotension). Produodopa can make these dizzy feelings worse. Slowly moving from a lying to a standing position can make you feel less dizzy.
Do not use Produodopa if you are taking
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
Produodopa is not recommended during pregnancy or in women of childbearing potential not using contraception unless the benefits for the mother outweigh the possible risk to the unborn baby.
It is not known if Produodopa passes into breast milk. Breast feeding should be discontinued during Produodopa therapy.
Do not drive or use any tools or machines until you are sure how Produodopa affects you.
Do not drive or use any tools or machines until you feel fully awake again or you no longer feel light-headed or dizzy.
Talk to your doctor or pharmacist if you need 9 ml or more of Produodopa on a daily basis for a prolonged period, especially if you have been advised to follow a low salt (sodium) diet.
Always use this medicine exactly as your doctor, nurse, or pharmacist has told you. Check with your doctor, nurse, or pharmacist if you have questions.
Read section 7 “Instructions for Use for Produodopa infusion using the Vyafuser pump” before using Produodopa.
If you have used more Produodopa than you should, stop the infusion immediately and talk to your doctor or go to a hospital straight away. Take the medicine pack with you. The following effects may happen
If you forget to use Produodopa, start your pump with your normal dose as soon as possible.
Produodopa can be interrupted for brief periods of time, such as when taking a shower. Make sure to change your infusion set (tubing and cannula) and rotate to a different infusion site if you interrupt the infusion for longer than 1 hour. For interruptions longer than 3 hours, you may need to also self-administer a loading dose to quickly re-establish your symptom control. The loading dose option is available in your pump as set by your doctor or nurse.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop using Produodopa and tell your doctor right away, if you notice any of the following serious side effects. You might need urgent medical treatment.
Your doctor will decide if you can keep using Produodopa.
Tell your doctor, pharmacist, or nurse if you notice any of the following side effects.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Impulse control disorders – changes in your behaviour. These are common, may affect up to 1 in 10 people.
Some people are unable to resist the impulse to do something that could be harmful to themselves or others. This may include
Tell your doctor if you, your family, or carer notice any of these behaviours. Your doctor may need to review your treatment. They will discuss ways of managing or reducing these symptoms with you.
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.
United Kingdom
Or search for MHRA Yellow Card in the Google Play or Apple App Store
Ireland
Keep this medicine out of the sight and reach of children.
Keep the vials in the outer carton in order to protect the vials from breaking.
Do not use this medicine after the expiry date which is stated on the vial label and carton. The expiry date refers to the last day of that month.
Produodopa is a clear to slightly opalescent, particle free, solution provided in a clear, colourless glass vial closed with a grey rubber stopper and a turquoise plastic cap. The colour of the solution may vary from colourless to yellow to brown, and it may have a purple or red tint. Variations in colour are expected and have no impact on medicine quality. The solution may become darker in colour after piercing of the vial stopper or while in the syringe.
Each pack contains 7 vials of 10 ml each.
Sterile, single-use infusion components (syringe, infusion set and vial adapter) qualified for use, are provided separately by your doctor or pharmacy. The Vyafuser pump is provided separately.
This leaflet was last revised in 11/2023
For information in large print, tape, CD or Braille, phone 01628 561090 (UK) or 01 428 7900 (Ireland).
Other sources of information
Detailed information on this medicine is available on the website of Medicines and Healthcare products Regulatory Agency; www.mhra.gov.uk, or on the website of Health Products Regulatory Authority; www.hpra.ie
Please read all of the section below before using Produodopa
Read the instructions below carefully – these instructions explain how to prepare and use Produodopa.
1. Setting up
Follow the steps below every time you need to refill your pump with Produodopa.
2. Preparing the solution vial
1) Prepare solution vial.
a. Remove the plastic cap from the solution vial.
b. Wipe the top of the solution vial with an alcohol pad and allow to dry.
2) Attach vial adapter to solution vial
Your vial adapter may look different from the one shown in this section.
a. Peel off the paper cover from the vial adapter packaging. Keep the adapter in the plastic packaging for step 3.
b. Use the packaging to push the vial adapter firmly, straight down onto the solution vial until it snaps into place.
c. Pull the packaging straight off the vial adapter.
For detailed information see the vial adapter instructions for use.
3) While holding the vial adapter firmly, attach the syringe to the vial adapter by pushing and then screwing it into place (clockwise). Do not overtighten.
4) Turn it upside down and hold the syringe vertically with the solution vial on top.
5) It is important to hold the syringe pointing straight up.
6) While holding the syringe firmly in one hand, pull down the plunger rod with the other hand to withdraw the full contents of the solution vial into the syringe to around the 12 ml mark or until you see air at the tip of the syringe.
a. Make sure you withdraw the entire contents of the solution vial into the syringe.
b. You will see air (head space) at the tip of the syringe.
7) Inspect for air bubbles.
a. Small bubbles are acceptable and the air at the tip of the syringe is expected If you see small air bubbles or do not see any bubbles, skip the next section and go to Step 9: Push air out of the syringe.
b. If there are large air bubbles, they must be removed. If you see large air bubbles, continue to the next section, Step 8: Manually remove air bubbles.
8) Manually remove air bubbles
a. Slowly and gently rotate the syringe and tilt it back and forth. This will gather the bubbles into a single bubble. Do not shake or tap the syringe to remove the air bubbles.
b. If there are still air bubbles, gather the bubbles by gently rotating the syringe end over end.
c. When the large bubbles have gathered into one bubble continue with the next step.
9) Push air out of the syringe.
a. With the solution vial still attached, point the syringe upward.
b. Slowly push the air out of the syringe and into the vial. Some resistance will be felt as the air is pushed back into the solution vial.
c. Continue pushing until all of the air is pushed out of the syringe and into the solution vial and there is solution visible in the syringe tip.
d. If you are tilting the syringe, you may see a small air bubble in the corner. This is acceptable.
10) Turn over the syringe and solution vial so that the solution vial is upright on the flat surface.
11) Disconnect the syringe from the vial adapter.
a. Hold the vial adapter firmly with one hand and the barrel of the syringe with the other.
b. Unscrew the syringe from the vial adapter. When disconnecting the syringe from the vial, do not push the plunger or the solution will leak.
c. Place the syringe on a clean surface, making sure the syringe tip does not contact an unclean surface.
12) Your syringe is now ready for use.
3. Setting up your Produodopa infusion
4. Choosing and preparing the infusion site
See infusion set instructions for use and patient instructions for use of Vyafuser pump for detailed instructions.
5. Start Produodopa infusion
Pump delivery options
Purpose:
When it is available:
The pump has alternative delivery options available which can be set up by your doctor if needed.
6. After Use
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
www.abbviemedinfo.com
+44 (0)1628 561 092
+44 (0)1628 561 092
www.abbvie.co.uk
0800 783 1699